Could targeting retinal non-perfusion be the key to achieving true disease modification in diabetic retinopathy?

News
Article

Advertorial: Could targeting retinal non-perfusion be the key to achieving true disease modification in diabetic retinopathy?


The triad of inflammation, neuropathy, and vasculopathy plays a key role in the development and progression of diabetic retinopathy (DR). Dr. Varun Chaudhary and Dr. Patrick Bussfeld, discuss how retinal non-perfusion (RNP) specifically drives disease progression and why it should be explored as a treatment target.

Newsletter

Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.

Recent Videos
© 2025 MJH Life Sciences

All rights reserved.